OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Huperzine A as a neuroprotective and antiepileptic drug: a review of preclinical research
Ugur Damar, Roman Gersner, Joshua T. Johnstone, et al.
Expert Review of Neurotherapeutics (2016) Vol. 16, Iss. 6, pp. 671-680
Closed Access | Times Cited: 74

Showing 1-25 of 74 citing articles:

Role of Cholinergic Signaling in Alzheimer’s Disease
Zhi-Ru Chen, Jiabao Huang, Shu‐Long Yang, et al.
Molecules (2022) Vol. 27, Iss. 6, pp. 1816-1816
Open Access | Times Cited: 390

Naturally Occurring Acetylcholinesterase Inhibitors and Their Potential Use for Alzheimer's Disease Therapy
Thaiane Coelho dos Santos, Thaís Mota Gomes, Bruno Pinto, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 322

Cholinergic System and Its Therapeutic Importance in Inflammation and Autoimmunity
Namrita Halder, Girdhari Lal
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 124

Huperzine A and Its Neuroprotective Molecular Signaling in Alzheimer’s Disease
María Jesús Friedli, Nibaldo C. Inestrosa
Molecules (2021) Vol. 26, Iss. 21, pp. 6531-6531
Open Access | Times Cited: 74

The endophytic Fusarium strains: a treasure trove of natural products
Arwa Mortada Ahmed, Basma Khalaf Mahmoud, Natalie Millán‐Aguiñaga, et al.
RSC Advances (2023) Vol. 13, Iss. 2, pp. 1339-1369
Open Access | Times Cited: 31

Therapeutic Potential of Natural Compounds in Neurodegenerative Diseases: Insights from Clinical Trials
Stéphanie Andrade, Débora Nunes, Meghna Dabur, et al.
Pharmaceutics (2023) Vol. 15, Iss. 1, pp. 212-212
Open Access | Times Cited: 28

Mechanism of NLRP3 Inflammasome in Epilepsy and Related Therapeutic Agents
Juan Chen, Yuan Gao, Ning Liu, et al.
Neuroscience (2024) Vol. 546, pp. 157-177
Closed Access | Times Cited: 9

Anti-Neuroinflammatory Potential of Natural Products in the Treatment of Alzheimer’s Disease
Mingzhenlong Deng, Wanli Yan, Zhicheng Gu, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 1486-1486
Open Access | Times Cited: 19

Alkaloids as drug leads in Alzheimer's treatment: Mechanistic and therapeutic insights
Md. Rezaul Islam, Shopnil Akash, Mohammed Murshedul Islam, et al.
Brain Research (2024) Vol. 1834, pp. 148886-148886
Closed Access | Times Cited: 8

A resurging boom in new drugs for epilepsy and brain disorders
Iyan Younus, Doodipala Samba Reddy
Expert Review of Clinical Pharmacology (2017) Vol. 11, Iss. 1, pp. 27-45
Closed Access | Times Cited: 60

A Review of Plant Extracts and Plant-Derived Natural Compounds in the Prevention/Treatment of Neonatal Hypoxic-Ischemic Brain Injury
Hadi Mohsenpour, Mirko Pesce, Antonia Patruno, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 2, pp. 833-833
Open Access | Times Cited: 33

Small-molecule drugs development for Alzheimer's disease
Weiwei Yao, Huihui Yang, Jinfei Yang
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 23

Huperzine A ameliorates neurological deficits after spontaneous subarachnoid hemorrhage through endothelial cell pyroptosis inhibition
Qiang Hu, Rong Zhang, Xiao‐Qiao Dong, et al.
Acta Biochimica et Biophysica Sinica (2024)
Open Access | Times Cited: 5

Novel acetylcholinesterase inhibitors from Zijuan tea and biosynthetic pathway of caffeoylated catechin in tea plant
Wei Wang, Xi-Wen Fu, Xinlong Dai, et al.
Food Chemistry (2017) Vol. 237, pp. 1172-1178
Closed Access | Times Cited: 47

Huperzine A: A promising anticonvulsant, disease modifying, and memory enhancing treatment option in Alzheimer’s disease
Ugur Damar, Roman Gersner, Joshua T. Johnstone, et al.
Medical Hypotheses (2016) Vol. 99, pp. 57-62
Closed Access | Times Cited: 40

Alteration in the Function and Expression of SLC and ABC Transporters in the Neurovascular Unit in Alzheimer’s Disease and the Clinical Significance
Yongming Jia, Na Wang, Yingbo Zhang, et al.
Aging and Disease (2020) Vol. 11, Iss. 2, pp. 390-390
Open Access | Times Cited: 38

Mechanism of cell death pathways in status epilepticus and related therapeutic agents
Ke Du, Miao He, Dongyi Zhao, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 149, pp. 112875-112875
Open Access | Times Cited: 21

A review of dementia, focusing on the distinct roles of viral protein corona and MMP9 in dementia: Potential pharmacotherapeutic priorities
Siva Prasad Panda, Urvashi Soni
Ageing Research Reviews (2022) Vol. 75, pp. 101560-101560
Closed Access | Times Cited: 19

Huperzine A injection ameliorates motor and cognitive abnormalities via regulating multiple pathways in a murine model of Parkinson's disease
Xinran Guo, Yuhan Wu, Qingqing Wang, et al.
European Journal of Pharmacology (2023) Vol. 956, pp. 175970-175970
Closed Access | Times Cited: 13

Huperzine a ameliorates sepsis-induced acute lung injury by suppressing inflammation and oxidative stress via α7 nicotinic acetylcholine receptor
Jingqian Su, Kunsen Chen, Xiao Sang, et al.
International Immunopharmacology (2024) Vol. 141, pp. 112907-112907
Closed Access | Times Cited: 4

Safety and tolerability profile of new antiepileptic drug treatment in children with epilepsy
Romina Moavero, Laura Rosa Pisani, Francesco Pisani, et al.
Expert Opinion on Drug Safety (2018) Vol. 17, Iss. 10, pp. 1015-1028
Closed Access | Times Cited: 36

Huperzine A ameliorates cognitive dysfunction and neuroinflammation in kainic acid‐induced epileptic rats by antioxidant activity and NLRP3/caspase‐1 pathway inhibition
Parvaneh Mohseni‐Moghaddam, Seyed Shahabeddin Sadr, Mehrdad Roghani, et al.
Clinical and Experimental Pharmacology and Physiology (2019) Vol. 46, Iss. 4, pp. 360-372
Closed Access | Times Cited: 33

Endophytic Fungal Community of Huperzia serrata: Diversity and Relevance to the Production of Huperzine A by the Plant Host
Lingli Cui, Hamza Armghan Noushahi, Yipeng Zhang, et al.
Molecules (2021) Vol. 26, Iss. 4, pp. 892-892
Open Access | Times Cited: 27

Integrated bioinformatic analysis reveals the underlying molecular mechanism of and potential drugs for pulmonary arterial hypertension
Haoru Dong, Xiuchun Li, Mengsi Cai, et al.
Aging (2021) Vol. 13, Iss. 10, pp. 14234-14257
Open Access | Times Cited: 24

Page 1 - Next Page

Scroll to top